Some cannabis gummies lower chronic pain. The effect depends on the cannabinoid, the dose, and the person. Reviews disagree on how large the effect is. The FDA has not approved any cannabis product for pain.
What the evidence shows
A 2017 report from the National Academies of Sciences, Engineering, and Medicine found substantial evidence that cannabis and cannabinoids reduce chronic pain in adults. A 2015 meta-analysis in JAMA covered 79 trials and 6,462 people. It found that cannabinoids raised the odds of a 30 percent or greater pain reduction. The result for neuropathic pain alone was not significant.
A 2020 task force of the International Association for the Study of Pain reviewed the same literature and reported no convincing evidence for chronic pain. The gap comes from small trials, short follow-up, and different pain types.
THC gummies and CBD gummies
THC binds CB1 and CB2 receptors in the brain and immune system. It causes impairment and euphoria. CBD does not bind CB1 in a direct way. The FDA approved a CBD drug, Epidiolex, for severe seizure disorders. That approval does not cover pain.
- Hemp gummies: 0.3 percent THC or less by dry weight. Legal at the federal level under the 2018 Farm Bill.
- State cannabis gummies: 2 to 10 mg THC per piece in most states with legal programs.
- CBD doses in clinical trials ran 100 to 600 mg per day. Retail gummies often hold 10 to 50 mg per piece.
Onset and duration
Edible gummies pass through the stomach and liver before the drug reaches the blood. Onset runs 30 to 120 minutes. Peak plasma levels arrive at 2 to 4 hours. Effects last 4 to 8 hours, longer with a big dose or a high-fat meal. Oral THC bioavailability is about 6 percent. Inhaled THC runs 10 to 35 percent. This gap explains why one gummy can hit harder than several puffs.
Dosing
- Start at 2.5 to 5 mg THC, or 10 to 25 mg CBD.
- Wait 2 hours before adding more.
- Keep the package and note the batch number.
- Do not drive after THC. Impairment peaks with the drug.
People over 65 and people who have not used cannabis before start lower. Tolerance builds with frequent use.
Legal status in the US
Hemp-derived CBD with 0.3 percent THC or less is legal under federal law. Cannabis with more THC stays Schedule I. State rules differ. Some states allow adult use, some allow medical use only, and a few allow neither. Crossing a state line with a THC product can break federal law.
Risks and interactions
THC causes dry mouth, fast heart rate, anxiety, and impaired memory. About 3 in 10 people who use cannabis develop a use disorder, per the CDC. Risk rises with daily use and early first use. Heavy long-term use can cause cannabinoid hyperemesis syndrome, with repeated vomiting and abdominal pain.
CBD inhibits the liver enzymes CYP2C19 and CYP3A4. This can raise blood levels of warfarin, clobazam, and other drugs. The FDA has warned about liver injury from CBD. Check with a clinician who knows your drug list.
Check the lab test
A certificate of analysis lists cannabinoid potency, THC content, pesticides, heavy metals, residual solvents, and microbials. Look for the batch number on the COA and on the package. A 2017 study in JAMA tested 84 CBD products. It found 26 percent held less CBD than the label claimed, 43 percent held more, and 21 percent held THC. Third-party labs test better than in-house labs. Ask which lab ran the test.
Bottom line
Gummies are a slow, long-acting option. THC products have the better evidence for pain, and they carry impairment and dependence risk. CBD products have weaker evidence for pain and a safer profile. Start low, wait two hours, and read the COA.